SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-135165
Filing Date
2019-05-02
Accepted
2019-05-02 17:02:15
Documents
77
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d732598d10q.htm 10-Q 933106
2 EX-31.1 d732598dex311.htm EX-31.1 6417
3 EX-31.2 d732598dex312.htm EX-31.2 6336
4 EX-32.1 d732598dex321.htm EX-32.1 3986
5 EX-32.2 d732598dex322.htm EX-32.2 3916
  Complete submission text file 0001193125-19-135165.txt   5255181

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zyme-20190331.xml EX-101.INS 891941
7 XBRL TAXONOMY EXTENSION SCHEMA zyme-20190331.xsd EX-101.SCH 63010
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zyme-20190331_cal.xml EX-101.CAL 83476
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zyme-20190331_def.xml EX-101.DEF 302013
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20190331_lab.xml EX-101.LAB 428651
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20190331_pre.xml EX-101.PRE 455920
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38068 | Film No.: 19792827
SIC: 2834 Pharmaceutical Preparations